Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.
Mucopolysaccharidosis Type I (MPS I) is the lysosomal storage disease caused by the deficient activity of alpha-L-iduronidase (IDUA). In man, MPS I can occur in severe, mild, or intermediate forms known as the Hurler, Scheie, or Hurler/Scheie syndromes, respectively. MPS I also has been described in cats, dogs, and mice. This manuscript reports the identification and characterization of the mutation causing MPS I in cats. To obtain wild-type feline IDUA cDNAs, two PCR-based strategies were used. PCR primers were constructed from a conserved region of the published human and dog sequences and used to amplify a 224-bp IDUA fragment from normal cat genomic DNA. This fragment was then used to screen a feline uterus cDNA library. PCR also was used to directly amplify IDUA fragments from the same cDNA library. Two overlapping feline IDUA cDNAs encoding 466 amino acid residues of the feline IDUA polypeptide ( approximately 85% of the mature protein based on comparison to the human, dog, and mouse sequences) were obtained by these strategies. To identify the mutation causing MPS I in cats, DNA sequencing was carried out on the corresponding IDUA region from several affected animals. A 3-bp deletion was found on both IDUA alleles in each of the MPS I animals, predicting the deletion of a single aspartate residue from the feline IDUA polypeptide. To confirm the authenticity of this mutation, heteroduplex, SSCP, and transient expression studies were carried out. Over 100 animals from the MPS I colony were screened for the presence of the mutation by heteroduplex and SSCP analyses-in all cases the presence of the 3-bp deletion was 100% concordant with the disease phenotype. For transient expression studies, the two partial, overlapping feline cDNAs were combined and joined in-frame to the 5' end of the canine IDUA cDNA. This wild-type, hybrid cDNA expressed IDUA activity up to sixfold over endogenous levels after transfection into COS-1 cells. A modified full-length IDUA cDNA containing the 3-bp deletion did not express IDUA activity in a transient expression system, providing proof that this lesion was the cause of feline MPS I.
He
X
X
Department of Human Genetics, Mount Sinai School of Medicine, New York 10029, USA.
Li
C M
CM
Simonaro
C M
CM
Wan
Q
Q
Haskins
M E
ME
Desnick
R J
RJ
Schuchman
E H
EH
D000818:Animals; D002415:Cats; D018076:DNA, Complementary / Q000302:isolation & purification; D004195:Disease Models, Animal; D004285:Dogs; D015870:Gene Expression; D006801:Humans; D007068:Iduronidase / Q000096:biosynthesis / Q000235:genetics*; D051379:Mice; D009083:Mucopolysaccharidoses / Q000201:enzymology* / Q000209:etiology / Q000235:genetics*; D016297:Mutagenesis, Site-Directed; D017384:Sequence Deletion
D018076:DNA, Complementary; D007068:Iduronidase